ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
2,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
3,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
4,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
5,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
6,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
7,1,Sperm concentration decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
8,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
8,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
10,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
11,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
12,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
12,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
12,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
12,5,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,1,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
14,1,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
15,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
16,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
17,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
18,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
19,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
21,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
22,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
23,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
24,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
25,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
25,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
25,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
26,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
27,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
27,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
28,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
29,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
30,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
31,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
32,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
33,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
34,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
34,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
34,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
34,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
34,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
35,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
36,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
38,1,Encapsulating peritoneal sclerosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
39,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
40,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
41,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
41,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
42,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
43,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
43,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
44,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
44,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
44,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
45,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
46,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
47,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
48,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
49,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
49,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
50,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
50,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
51,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
52,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
53,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,Y
54,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
55,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
56,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
57,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
58,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
59,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
60,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
60,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
61,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
61,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
62,1,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
63,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
63,2,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
64,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
65,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
66,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
66,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
67,1,Headache,Headaches NEC,Headaches,Nerv,N
67,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
68,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
68,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
68,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
68,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
68,5,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
68,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
69,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
69,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
70,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
70,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
71,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
71,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
71,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
72,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
73,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
73,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
73,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
74,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
74,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
74,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
74,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
74,5,Headache,Headaches NEC,Headaches,Nerv,N
74,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
74,7,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
75,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
76,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
76,2,Homicide,Criminal activity,Legal issues,SocCi,N
77,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
77,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
77,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
77,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
77,5,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
77,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
78,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
79,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
79,2,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
80,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
81,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
82,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
82,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
82,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
82,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
83,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
84,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
85,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
85,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
86,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
86,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
86,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
86,4,Delusion of replacement,Delusional symptoms,Disturbances in thinking and perception,Psych,N
86,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
86,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
87,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
87,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
88,1,Cerebellar atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
89,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
89,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
89,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
90,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
90,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
91,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
92,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
92,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
93,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
93,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
93,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
93,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
94,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
95,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
95,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
96,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
97,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
97,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
98,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
98,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
99,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
100,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
101,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
101,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
102,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
103,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
104,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
104,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
105,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
105,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
105,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
106,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
107,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
107,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
108,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
108,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
108,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
110,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
111,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
111,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
112,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
113,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
113,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
115,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
116,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
116,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
117,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
118,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
119,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
120,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
120,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
121,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
122,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
122,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
122,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
123,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
124,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
125,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
125,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
125,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
125,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
126,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
127,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
127,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
129,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
129,2,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
129,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
130,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
131,1,Acute cholecystitis necrotic,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
131,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
132,1,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
132,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
133,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
134,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
134,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
134,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
135,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
135,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
135,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
136,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
136,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
136,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
137,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
137,2,Myopathy,Myopathies,Muscle disorders,Musc,N
138,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
139,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
139,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
139,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
139,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
140,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
141,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
142,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
143,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
144,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
144,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
145,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
145,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
145,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
146,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
146,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
146,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
146,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
146,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
146,6,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
147,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
147,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
147,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
148,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
149,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
149,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
149,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
150,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
150,2,Salivary gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
151,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
152,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
153,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
154,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
155,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
156,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
157,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
158,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
159,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
160,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
161,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
161,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
161,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
162,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
164,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
164,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
165,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
166,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
166,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
167,1,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
168,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
169,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
169,2,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
170,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
171,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
172,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
173,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
174,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
175,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
176,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
177,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
178,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
178,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
178,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
178,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
179,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
179,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
179,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
180,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
181,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
182,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
182,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
182,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
183,1,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
184,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
185,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
186,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
186,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
186,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
186,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
188,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
189,1,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
189,2,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
189,3,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
190,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
190,2,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
190,3,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
190,4,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
190,5,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
191,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,Y
192,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
193,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
194,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
194,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
195,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
195,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
195,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
196,1,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
196,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
196,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
197,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
198,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
199,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
200,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
201,1,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
202,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
203,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
204,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
204,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
205,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
206,1,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
207,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
207,2,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
208,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
209,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
209,2,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
209,3,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
209,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
210,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
210,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
211,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
212,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
212,2,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
212,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
213,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
214,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
215,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
216,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
217,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
218,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
219,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
220,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
220,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
220,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
220,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
220,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
220,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
221,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
222,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
223,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
224,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
225,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
226,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
226,3,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
226,4,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
227,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
228,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
228,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
228,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
228,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
228,5,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
228,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
229,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
230,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
230,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
231,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
231,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
232,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
232,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
232,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
232,4,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
232,5,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
232,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
232,7,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
232,8,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
232,9,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
233,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
233,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
233,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
233,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
233,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
233,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
233,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
234,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
234,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
235,1,Retinal depigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
235,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
236,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
237,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
238,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
238,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
238,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
239,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
240,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
241,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
241,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
242,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
242,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
242,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
243,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
243,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
244,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
244,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
245,1,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
246,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
247,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
248,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
249,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
250,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
251,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
251,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
251,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
252,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
252,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
253,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
253,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
253,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
254,1,Deafness,Hearing losses,Hearing disorders,Ear,N
255,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
255,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
256,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
257,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
258,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
259,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
260,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
262,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
263,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
263,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
263,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
264,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
265,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
266,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
267,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
268,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
268,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
269,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
270,1,Acne,Acnes,Skin appendage conditions,Skin,N
270,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
270,3,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
271,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
272,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
273,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
273,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
274,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
274,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
275,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
276,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
277,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
277,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
278,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
278,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
278,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
279,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
280,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
281,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
282,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
283,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
284,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
284,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
285,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
286,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
286,2,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
286,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
286,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
286,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
286,6,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
286,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
286,8,Mutism,Communications disorders,Communication disorders and disturbances,Psych,N
286,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
287,1,Headache,Headaches NEC,Headaches,Nerv,N
287,2,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
288,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
289,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
289,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
289,3,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
289,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
289,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
290,1,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
290,2,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
291,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
291,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
291,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
292,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
292,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
293,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
294,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
295,1,Rubinstein-Taybi syndrome,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
296,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
297,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
298,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
298,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
298,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
299,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
300,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
301,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
302,1,Acne,Acnes,Skin appendage conditions,Skin,N
303,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
304,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
304,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
305,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
306,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
307,1,Deafness,Hearing losses,Hearing disorders,Ear,N
307,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
308,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
309,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
310,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
310,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
310,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
310,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
311,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
311,2,Lymphocytic leukaemia,Leukaemias lymphocytic NEC,Leukaemias,Neopl,N
312,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
312,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
312,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
312,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
312,5,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
313,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
313,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
313,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
314,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
315,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
316,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
316,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
317,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
317,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
317,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,1,Progressive cerebellar degeneration,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
319,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
320,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
320,2,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
321,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
321,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,1,Retinal vascular disorder,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
322,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
323,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
323,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
324,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
325,1,Small intestine carcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
326,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
327,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
328,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
329,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
329,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
329,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
329,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
330,1,Testicular disorder,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
331,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
331,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
332,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
333,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
333,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
333,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
333,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
333,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
333,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
333,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
334,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
335,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
335,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
336,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
337,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
338,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
338,2,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
338,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
338,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
339,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
339,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
340,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
341,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
342,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
343,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
344,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
344,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
345,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
346,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
347,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
347,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
347,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
348,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
349,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
349,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
349,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
349,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
350,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
351,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
352,1,Pyloric stenosis,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
353,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
354,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
354,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
355,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
355,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
356,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
357,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
357,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
358,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
358,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
358,3,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
360,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
361,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
361,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
361,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
361,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
361,5,Headache,Headaches NEC,Headaches,Nerv,N
361,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
362,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
363,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
364,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
364,2,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
364,3,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
364,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
364,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
364,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
365,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,2,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
366,1,Congenital hiatus hernia,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
367,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
368,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
369,1,Toxic goitre,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
370,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
371,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
372,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
373,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
374,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
375,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
375,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
375,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
375,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
375,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
376,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
376,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
376,3,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,Y
377,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
378,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
378,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,3,Ketosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
378,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
378,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
380,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
380,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
380,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
380,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
380,5,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
380,6,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
381,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
382,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
383,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
384,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
385,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
386,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
387,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
388,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
388,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
389,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
390,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
390,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
390,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
390,4,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
390,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
390,6,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
391,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
391,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
391,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
391,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
391,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
391,6,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
392,1,Stomatitis necrotising,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
393,1,Acne,Acnes,Skin appendage conditions,Skin,N
394,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
395,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
395,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
396,1,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
396,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
396,3,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
397,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
397,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
398,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
399,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
399,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
399,3,Thyroxine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
399,4,Tri-iodothyronine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
400,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
400,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
401,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
402,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
402,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
403,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
404,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
405,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
406,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
407,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
408,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
409,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
410,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
411,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
412,1,Retinal pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
413,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
414,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
415,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
415,2,Hypotonia neonatal,Muscle tone abnormalities,Muscle disorders,Musc,N
415,3,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
415,4,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
416,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
417,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
418,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
419,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
420,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
421,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
422,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
423,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
423,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
423,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
424,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
424,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
424,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
425,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
426,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
426,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
427,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
428,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
428,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
428,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
428,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
428,5,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
429,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
430,1,Congenital hypothyroidism,Thyroid disorders congenital,Endocrine disorders congenital,Cong,N
430,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
430,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
431,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
431,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
431,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
432,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
432,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
432,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
432,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
433,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
434,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
434,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
435,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
436,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
437,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
438,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
439,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
439,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
440,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
441,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
442,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
443,1,Toxic goitre,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
444,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
445,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
446,1,Microphthalmos,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
447,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
447,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
447,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
447,5,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
447,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
447,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
447,8,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
447,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
448,1,Infertility male,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
449,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
450,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
451,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
451,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
452,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
453,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
454,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
454,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
455,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
455,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
456,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
457,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
458,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
459,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
459,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
460,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
461,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
462,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
463,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
464,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
465,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
466,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
467,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
468,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
469,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
470,1,Gastrointestinal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
471,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
471,2,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
471,3,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
471,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
471,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
472,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
473,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
473,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
474,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
475,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
475,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
475,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
476,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
477,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
478,1,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
478,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
479,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
480,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
481,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
482,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
483,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
483,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
483,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
484,1,Acne,Acnes,Skin appendage conditions,Skin,N
485,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
486,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
486,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
486,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
487,1,Cataract congenital,Lens disorders congenital,Eye disorders congenital,Cong,N
488,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
489,1,Acne,Acnes,Skin appendage conditions,Skin,N
490,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
491,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
492,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
493,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,Y
493,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
493,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
494,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
494,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
494,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
494,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
494,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
494,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
495,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
496,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
497,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
498,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
499,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
499,2,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
499,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
500,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
501,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
501,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
501,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
501,4,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
501,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
501,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
501,7,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
501,8,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
502,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
503,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
504,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
504,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
505,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
506,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
506,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
507,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
508,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
508,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
509,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
510,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
511,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
512,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
513,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
514,1,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
514,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
515,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
516,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
517,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
517,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
517,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
518,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
519,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
520,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
520,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
520,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
521,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
521,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
521,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
522,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
522,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
522,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
523,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
524,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
525,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
526,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
526,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
527,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
527,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
527,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
527,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
528,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
529,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
530,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
531,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
532,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
533,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
533,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
534,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
534,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
535,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
535,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
535,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
536,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
537,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
537,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
539,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
540,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
541,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
542,1,Leukaemia monocytic,Leukaemias myeloid NEC,Leukaemias,Neopl,N
543,1,Semen analysis abnormal,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
544,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
544,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
544,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
544,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
544,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
544,6,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
545,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
545,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
546,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
547,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
548,1,Acne,Acnes,Skin appendage conditions,Skin,N
549,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
549,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
550,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
551,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
552,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
553,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
553,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
553,3,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
553,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
554,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
555,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
556,1,Acne,Acnes,Skin appendage conditions,Skin,N
557,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
558,1,Acne,Acnes,Skin appendage conditions,Skin,N
558,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
559,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
560,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
562,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
562,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
563,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
564,1,Deafness,Hearing losses,Hearing disorders,Ear,N
565,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
566,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
567,1,Headache,Headaches NEC,Headaches,Nerv,N
567,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
568,1,Acne,Acnes,Skin appendage conditions,Skin,N
569,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
569,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
569,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
569,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
569,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
570,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
571,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
572,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
573,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
574,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
575,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
576,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
577,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
577,2,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
578,1,Acne,Acnes,Skin appendage conditions,Skin,N
579,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
579,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
580,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
581,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
581,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
582,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
583,1,Myopathy,Myopathies,Muscle disorders,Musc,N
584,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
584,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
585,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
586,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
587,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
588,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
589,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
590,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
590,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
591,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
592,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
592,2,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
593,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
594,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
594,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,Y
595,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
596,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
596,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
596,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,4,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
596,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
596,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
596,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
597,1,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
598,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
599,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
599,2,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
600,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
601,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
601,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
601,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
601,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
601,5,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
601,6,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
601,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
602,1,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
603,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
604,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
604,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
605,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
606,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
607,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
608,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
608,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
609,1,Headache,Headaches NEC,Headaches,Nerv,N
609,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
610,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
610,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
610,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
610,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
611,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
612,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
612,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
612,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
612,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
613,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
614,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
615,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
615,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
616,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
617,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
618,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
618,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
619,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
620,1,Dermal cyst,Skin cysts and polyps,Cutaneous neoplasms benign,Skin,N
621,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
621,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
622,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,Y
623,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
623,2,Derealisation,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
623,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
623,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
623,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
624,1,Head titubation,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
625,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
626,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
627,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
628,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
628,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
628,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
629,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
630,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
631,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
632,1,Headache,Headaches NEC,Headaches,Nerv,N
632,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
632,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
632,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
632,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
633,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
634,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
635,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
635,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
636,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
636,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
637,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
637,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
638,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
638,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
638,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
638,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
638,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
639,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
639,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
640,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
640,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
641,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
642,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
642,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
643,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
644,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
645,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
646,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
646,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
647,1,Drop attacks,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
648,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
648,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
648,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
649,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
650,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
650,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
651,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
651,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
651,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
651,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
652,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
652,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
653,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
654,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
655,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
656,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
657,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
657,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
658,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
659,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
659,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
659,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
659,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
659,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
659,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
659,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
660,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
661,1,Deafness,Hearing losses,Hearing disorders,Ear,N
661,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
662,1,Deafness,Hearing losses,Hearing disorders,Ear,N
662,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
663,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
664,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
665,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
666,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
667,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
667,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
667,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
667,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
668,1,Lymphocytic leukaemia,Leukaemias lymphocytic NEC,Leukaemias,Neopl,N
668,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
669,1,Acne,Acnes,Skin appendage conditions,Skin,N
669,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
670,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
671,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
671,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
672,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
672,2,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
673,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
674,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
675,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
675,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
676,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
677,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
677,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
678,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
679,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
679,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
680,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
681,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
682,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
683,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
683,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
684,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
684,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
684,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
685,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
686,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
686,2,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
687,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
688,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
689,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
690,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
690,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
690,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
690,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
690,5,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
691,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
692,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
693,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
694,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
695,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
695,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
696,1,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
696,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
696,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
697,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
698,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
698,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
699,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
700,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
700,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
701,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
701,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
701,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
701,4,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
701,5,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
701,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
702,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
702,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
702,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
702,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,5,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
703,1,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
704,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
704,2,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
704,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
704,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
704,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
704,6,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
704,7,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
704,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
704,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
704,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
704,11,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
704,12,Thyroxine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
705,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
705,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
705,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
705,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
705,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
706,1,Xerophthalmia,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
707,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
707,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
708,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
708,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
709,1,Acne,Acnes,Skin appendage conditions,Skin,N
710,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
710,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
711,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
712,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
713,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
714,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
715,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
715,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
715,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
716,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
717,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
717,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
717,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
717,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
717,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
717,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
718,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
719,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
720,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
720,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
720,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
720,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
720,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
720,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
720,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
721,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
721,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
721,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
721,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
721,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
722,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
723,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
723,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
724,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
725,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,Y
726,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
726,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
726,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
727,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
727,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
728,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
728,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
729,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
729,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
730,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
731,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
731,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
731,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
731,4,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
731,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
732,1,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
733,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
734,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
735,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
735,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
736,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
736,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
736,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
736,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
737,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
738,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
739,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
740,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
741,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,2,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
741,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
741,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
742,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
743,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
743,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
745,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
745,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
746,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
746,2,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
746,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
746,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
746,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
746,6,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
747,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
748,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
748,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
748,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
749,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
749,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
750,1,Retinal pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
751,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
751,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
751,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
751,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
752,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
753,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
754,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
756,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
757,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
758,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
759,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
759,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
760,1,Retinal vascular disorder,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
761,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
761,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
762,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
763,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
763,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
764,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
765,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
765,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
765,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
766,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
766,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
767,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
768,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
768,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
769,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
770,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
771,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
772,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
773,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
773,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
773,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
774,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
774,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
774,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
774,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
775,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
776,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
777,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
778,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
778,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
778,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
778,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
778,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
779,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
780,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
781,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
782,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
782,2,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
783,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
783,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
784,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
784,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
784,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
785,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
785,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
786,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
787,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
787,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
788,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
789,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
789,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
790,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
791,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
791,2,Cor pulmonale,Right ventricular failures,Heart failures,Card,N
791,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
792,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
792,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
792,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
792,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
792,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
793,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
794,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
795,1,Cardiac murmur functional,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
795,2,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
796,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
797,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
798,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
798,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
799,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
799,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
799,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
800,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
801,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
801,2,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
802,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
802,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
802,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
802,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
802,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
803,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
804,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
805,1,Diabetic hyperosmolar coma,Coma states,Neurological disorders NEC,Nerv,N
806,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
806,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
806,3,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
806,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
807,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
807,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
807,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
807,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
808,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
809,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
810,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
810,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
810,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
810,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
810,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
810,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
811,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
811,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
811,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
811,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
811,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
811,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
811,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
811,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
811,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
812,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
813,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
813,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
813,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
814,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
814,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
814,3,Headache,Headaches NEC,Headaches,Nerv,N
814,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
815,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
816,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
816,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
816,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
816,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
817,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
817,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
818,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
819,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
819,2,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
820,1,Acne,Acnes,Skin appendage conditions,Skin,N
821,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
822,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
823,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
823,2,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
824,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
824,2,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
825,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
825,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
825,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
825,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
825,5,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
825,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
826,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
827,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
828,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
829,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
829,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
830,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
830,2,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
830,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
831,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
832,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
832,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
832,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
833,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
834,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
835,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
835,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
836,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
836,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
836,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
836,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
837,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
837,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
838,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
838,2,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
838,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
839,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
839,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
839,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
839,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
840,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
841,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
841,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
841,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
841,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
841,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
841,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
841,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
842,1,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
842,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
842,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
842,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
842,5,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
842,6,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
842,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
842,8,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
842,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
842,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
842,11,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
842,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
843,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
844,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
845,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
846,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
847,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
847,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
848,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
849,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
849,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
849,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
849,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
849,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
850,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
851,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
851,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
852,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
852,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
853,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
853,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
853,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
853,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
854,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
854,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
854,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
854,4,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
854,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
855,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
856,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
857,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
858,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
858,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
859,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
859,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
859,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
860,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
861,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
862,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
862,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
862,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
863,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
864,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
865,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
865,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
866,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
867,1,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
867,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
868,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
869,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
870,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
870,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
870,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
871,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
871,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
871,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
871,4,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
871,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
871,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
872,1,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
872,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
872,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
872,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
872,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
873,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
873,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
873,3,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
874,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
875,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
875,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
875,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
876,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
877,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
877,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
877,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
878,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
879,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
879,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
879,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
879,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
879,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
880,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
880,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
880,3,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
880,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
880,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
880,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
881,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
881,2,Cerebellar atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
881,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
881,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
882,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
883,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
883,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
883,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
884,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
884,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
885,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
885,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
885,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
885,4,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
885,5,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
885,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
886,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
887,1,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
887,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
888,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
889,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
890,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
891,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
892,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
893,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
893,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
893,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
893,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
893,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
894,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
894,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
894,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
894,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
895,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
895,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
895,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
895,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
896,1,Bundle branch block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
897,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
897,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
898,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
899,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
899,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
899,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
899,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
899,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
899,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
900,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
900,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
901,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
901,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
902,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
903,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
903,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
904,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
904,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
905,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
906,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
906,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
906,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
906,4,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
906,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
907,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
907,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
908,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
909,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
909,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
909,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
909,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
909,5,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
909,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
909,7,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
910,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
910,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
910,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
910,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
910,5,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
911,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
911,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
911,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
912,1,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
913,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
913,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
913,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
914,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
914,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
915,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
916,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
917,1,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
917,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
917,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
918,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
918,2,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
918,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
918,4,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
919,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
919,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
919,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
919,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
919,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
919,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
920,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
920,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
920,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
920,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
920,5,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
920,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
921,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
922,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
922,2,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
923,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
923,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
923,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
923,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
924,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
925,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
926,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
927,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
927,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
927,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
928,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
929,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
930,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
930,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
931,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
932,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
933,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
934,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
934,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
934,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
934,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
934,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
934,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
934,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
935,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
935,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
936,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
936,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
937,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
937,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
938,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
938,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
938,3,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
938,4,Gastric volvulus,Gastric and pyloric stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
938,5,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
938,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
938,7,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
938,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
939,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
939,2,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
939,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
940,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
940,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
940,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
940,5,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
940,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
940,7,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
940,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
940,9,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
940,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
940,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
941,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
941,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
941,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
941,4,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
942,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
943,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
943,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
943,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,4,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
943,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
943,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
944,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
944,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
944,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
945,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
946,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
947,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
949,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
949,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
950,1,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
951,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
951,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
952,1,Cogwheel rigidity,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
952,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
952,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
952,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
952,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
952,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
953,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
953,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
953,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
954,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
954,2,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
954,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
954,4,Nodal rhythm,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
955,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
956,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
957,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
957,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
958,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
959,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
960,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
961,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
961,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
962,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
963,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
964,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
964,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
964,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
964,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
965,1,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
965,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
966,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
966,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
967,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
967,2,Tri-iodothyronine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
968,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
968,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
969,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
970,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
970,2,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
970,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
970,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
970,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
970,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
971,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
971,2,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
972,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
973,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
974,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
975,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
975,2,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
975,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
976,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
977,1,Hypoplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
978,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
979,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
980,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
981,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
982,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
982,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
982,3,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
982,4,Prostatic disorder,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
982,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
982,6,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
982,7,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
982,8,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
982,9,Urethral disorder,Urethral disorders NEC,Urethral disorders (excl calculi),Renal,N
983,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
983,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
984,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
984,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
984,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
984,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
985,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
985,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
985,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
985,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
986,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
987,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
987,2,Porphyria non-acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
988,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
988,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
988,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
988,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
988,5,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
988,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
988,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
989,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
989,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
989,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
990,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
990,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
990,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
991,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
991,2,Gingival oedema,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
991,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
992,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
992,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
992,3,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
992,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
992,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
993,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
993,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
993,3,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
993,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
994,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
995,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
995,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
995,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
995,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
995,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
995,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
995,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
996,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
996,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
997,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
997,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
998,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
998,2,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
999,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
999,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1000,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1000,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1000,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1000,4,Fear of falling,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1000,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1001,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1002,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1003,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1003,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1003,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1003,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1003,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1003,6,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1003,7,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1003,8,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
1004,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1004,2,Polydipsia psychogenic,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
1004,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1005,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1006,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1007,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1007,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1007,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1008,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1008,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1009,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1010,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1010,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1011,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1011,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1012,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1012,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1013,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1013,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1014,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1014,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1014,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1015,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1015,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1016,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1016,2,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1016,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1016,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1016,5,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1016,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1016,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1016,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1016,9,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1017,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1017,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1017,3,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1017,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1017,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1017,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1017,7,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1018,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1018,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1018,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1019,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1019,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1020,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1020,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1020,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1021,1,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1022,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1022,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1023,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1023,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1024,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1025,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1025,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1025,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1026,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1027,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1027,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1027,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1027,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1028,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1029,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1029,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1029,4,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1029,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,6,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1029,7,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1029,8,Ketonuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1029,9,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1029,10,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1029,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1029,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1030,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1031,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1032,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1033,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1034,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1034,2,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1034,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1034,4,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1034,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1034,6,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1034,7,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1034,8,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1034,9,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1034,10,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1035,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1036,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1036,2,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1036,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1037,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1037,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1037,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1037,4,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1037,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1037,6,Senile dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1037,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1038,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1038,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1038,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1039,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1039,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1039,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1039,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1039,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1040,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1040,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1040,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1041,1,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1042,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1043,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1043,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1043,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1043,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1043,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1044,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1045,1,Antisocial behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1045,2,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1045,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1045,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1045,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1045,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1045,7,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1045,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1045,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1045,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1046,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1047,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1047,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1048,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1048,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1049,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1050,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1051,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1052,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1053,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1053,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1053,3,Migraine with aura,Migraine headaches,Headaches,Nerv,N
1053,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1054,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1054,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1054,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1055,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1055,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1055,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1055,4,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1055,5,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1055,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1055,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1055,8,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1055,9,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1055,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1055,11,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1055,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1055,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1056,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1056,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1056,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1056,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1056,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1056,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1057,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1057,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1058,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1059,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1059,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1059,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1060,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1061,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1061,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1062,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1062,2,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1062,3,Sinus arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1062,4,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1062,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1063,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1063,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1064,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1065,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1066,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1066,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1066,3,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1066,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1066,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1066,6,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
1066,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1066,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1067,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1067,2,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1067,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1067,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1067,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1068,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1068,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1069,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1069,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1069,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1070,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1070,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1070,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1071,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1072,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1072,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1073,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1073,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1074,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1075,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,Y
1076,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1077,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1077,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1078,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1079,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1080,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1080,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1080,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1080,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1080,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1080,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1080,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1080,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1080,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1081,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1081,2,Blood creatine phosphokinase,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1081,3,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1081,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1081,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1081,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1081,7,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1081,8,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1081,9,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1081,10,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1081,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1081,12,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1081,13,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
1082,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1083,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1083,2,Oligomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1083,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1084,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
1084,2,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1084,3,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
1085,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1085,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1085,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1085,4,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
1086,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1087,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1087,2,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1087,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1087,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1088,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1089,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1089,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1090,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1090,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1090,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1090,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1091,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1092,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1092,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1093,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1094,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1094,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1095,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1095,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1096,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1096,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1096,3,Blood osmolarity increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
1096,4,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1096,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1096,6,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1096,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1096,8,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1096,9,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1096,10,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1096,11,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1096,12,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1096,13,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1096,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1096,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1096,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1096,17,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1097,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1097,2,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1097,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1098,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1098,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1098,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1099,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1099,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1100,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1100,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1101,1,Oral dysaesthesia,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1101,2,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1102,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1102,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1103,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1104,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1104,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1104,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1104,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1105,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1106,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1106,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1106,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1106,4,Irregular sleep phase,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
1106,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1106,6,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1106,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1106,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1106,9,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1107,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1107,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1107,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1107,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1107,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1107,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1108,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
1108,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1108,3,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1108,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1108,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1108,6,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1108,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1108,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1109,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1109,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1109,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1110,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1110,2,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1110,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1110,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1110,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1110,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1110,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1111,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1111,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1112,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1112,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1112,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1112,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1113,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1113,2,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1114,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1114,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1114,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1114,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1114,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1115,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1115,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1116,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1116,2,Cerebellar atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1116,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1116,4,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1116,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1116,6,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1116,7,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1116,8,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1117,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1117,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1117,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1117,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1117,5,Urine osmolarity increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
1118,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1118,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1118,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1118,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1118,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1118,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1118,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1118,8,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1118,9,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1118,10,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1118,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1118,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1118,13,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1118,14,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1118,15,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1118,16,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1118,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1118,18,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1118,19,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1118,20,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1118,21,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1118,22,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1118,23,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1118,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1118,25,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1119,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1119,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1119,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1120,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1120,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1120,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1120,4,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1120,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1121,1,Acne,Acnes,Skin appendage conditions,Skin,N
1121,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1121,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1122,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1122,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1122,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1122,4,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1122,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1122,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1122,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1122,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1122,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1122,10,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1122,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1122,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1122,13,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1122,14,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1122,15,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1122,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1123,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1124,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1124,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1124,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1125,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1125,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1125,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1125,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1126,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1126,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1126,3,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1126,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1127,1,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1127,2,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1128,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1128,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1128,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1129,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1129,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1129,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1130,1,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1131,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1131,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1132,1,Acne,Acnes,Skin appendage conditions,Skin,N
1132,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1132,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1132,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1132,5,Ejaculation delayed,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1132,6,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1132,7,Headache,Headaches NEC,Headaches,Nerv,N
1132,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1132,9,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1132,10,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1132,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1132,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1132,13,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
1132,14,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1132,15,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1132,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1132,17,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1132,18,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1133,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1134,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1134,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1134,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1134,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1134,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1134,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1134,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1134,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1134,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1134,10,Urinary tract obstruction,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
1135,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1135,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1136,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1137,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1138,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1138,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1138,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1138,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1138,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1138,6,Headache,Headaches NEC,Headaches,Nerv,N
1138,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1138,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1138,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1138,10,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1138,11,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1138,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1138,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1138,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1139,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1139,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1139,3,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1139,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1139,5,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1139,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1139,7,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1139,8,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1139,9,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1139,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1139,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1139,12,Urinoma,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
1140,1,Magnetic resonance imaging head abnormal,Central nervous system imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1140,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1140,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1140,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1140,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1141,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1141,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1141,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1142,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1142,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1143,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1143,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1143,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1143,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1144,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1144,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1144,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1144,4,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
1145,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1145,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1145,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1146,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1146,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1146,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1146,4,Flashback,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
1146,5,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1146,6,Headache,Headaches NEC,Headaches,Nerv,N
1146,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1146,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1146,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1146,10,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1146,11,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1146,12,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1147,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1147,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1148,1,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1149,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1149,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1149,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1149,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1150,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1151,1,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1152,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1152,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1152,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1152,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1153,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1154,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1154,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1154,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1154,4,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1155,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1156,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1156,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1157,1,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1157,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1157,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1158,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1159,1,Headache,Headaches NEC,Headaches,Nerv,N
1159,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1159,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1159,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1160,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1160,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
1160,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1160,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1160,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1160,6,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1160,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1160,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1160,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1161,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1161,2,Deafness,Hearing losses,Hearing disorders,Ear,N
1161,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1161,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1161,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1161,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1162,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1163,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1163,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1163,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1163,4,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1163,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1163,6,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1163,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1163,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1163,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1163,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1163,11,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1163,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1163,13,Loss of employment,Employment issues,Economic and housing issues,SocCi,N
1163,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1163,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1163,16,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1163,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1164,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1164,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1164,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1164,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1165,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1165,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1165,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1165,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1165,5,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1165,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1165,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1166,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1166,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1167,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1167,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1167,3,Bronchial hyperreactivity,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1167,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1167,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1168,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1168,2,Hyperparathyroidism primary,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1168,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1168,4,Primary hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1169,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1169,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1169,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1169,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1170,1,Burning mouth syndrome,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1170,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1170,3,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
1170,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1170,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1171,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1171,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1171,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1171,4,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
1171,5,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1172,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1172,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1172,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1173,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1174,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1175,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1175,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1175,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1175,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1176,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1177,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1177,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1177,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1177,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1177,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1178,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1178,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1178,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1179,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1179,2,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
1179,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1180,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1180,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1180,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1180,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1180,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1180,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1180,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1181,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1182,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1182,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1183,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1183,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1183,3,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1184,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1184,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1184,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1185,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1185,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1185,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1185,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1185,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1185,6,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1185,7,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1185,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1185,9,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1186,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1186,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1187,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1187,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1187,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1187,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1187,5,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1187,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1188,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1188,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1189,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1189,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1189,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1189,4,Food aversion,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1189,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1189,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1190,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1191,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1192,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1192,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1192,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1192,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1192,5,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1192,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1193,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1194,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1194,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1194,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1194,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1195,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1195,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1195,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1195,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1195,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1195,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1196,1,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1197,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1197,2,Carcinoid syndrome,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
1197,3,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1197,4,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1197,5,Pulmonary valve incompetence,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
1197,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1197,7,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1198,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1198,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1198,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1198,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1199,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1199,2,Theft,Criminal activity,Legal issues,SocCi,N
1200,1,Otospondylomegaepiphyseal dysplasia,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
1201,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1201,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1201,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1202,1,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1202,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1202,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1203,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1203,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1203,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1204,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1205,1,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1205,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1206,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1206,2,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1206,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1207,1,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
1207,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1207,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1207,4,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1207,5,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1207,6,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1207,7,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1207,8,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1207,9,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1207,10,Hypotonia neonatal,Muscle tone abnormalities,Muscle disorders,Musc,N
1207,11,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1207,12,Infantile apnoea,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1207,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1207,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1208,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1208,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1208,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1208,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1209,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1210,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1210,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1211,1,Asterixis,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1211,2,Confabulation,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1211,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1211,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1211,5,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1211,6,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1211,7,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1211,8,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1211,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1211,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1211,11,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1211,12,Perseveration,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1211,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1212,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1212,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1212,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1212,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1212,5,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1212,6,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1212,7,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1212,8,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1212,9,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1212,10,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
1212,11,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
1212,12,Organic brain syndrome,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
1212,13,Palmomental reflex,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1212,14,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1213,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1214,1,Asterixis,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1214,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1214,3,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1214,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1214,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1214,6,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1214,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1214,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1214,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1214,10,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1214,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1214,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1214,13,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1214,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1215,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1215,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1215,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
1215,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1215,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1215,6,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1215,7,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1215,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1215,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1215,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1216,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1217,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1217,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
1217,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1217,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1217,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1218,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1218,2,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1218,3,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1218,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1219,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1219,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1219,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1219,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1219,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1219,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1219,7,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1219,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1219,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1219,10,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1219,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1219,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1219,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1220,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1220,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1220,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1220,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1220,5,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1220,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1220,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1220,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1221,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1222,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1222,2,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1222,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1222,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1222,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1223,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1223,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1223,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1223,4,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1223,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1223,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1223,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1223,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1223,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1223,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1223,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1224,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1224,2,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1224,3,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1225,1,Jaw disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1225,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1226,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1226,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1226,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1226,4,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1226,5,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1226,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1227,1,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1227,2,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1227,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1227,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1228,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1228,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1228,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1228,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1228,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1228,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1228,7,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1228,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1229,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1229,2,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1229,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1230,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1231,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1232,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1232,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1232,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1232,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1232,5,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1232,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1232,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1233,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1233,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1233,3,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1233,4,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1233,5,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1233,6,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1233,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1233,8,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1233,9,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1233,10,Impatience,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1233,11,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1233,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1233,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1233,14,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1234,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1235,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1235,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1235,3,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1235,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1235,5,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
1235,6,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1235,7,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1236,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1236,2,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1236,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1236,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1237,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1238,1,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1238,2,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1239,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1239,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1239,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1240,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1241,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1241,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1241,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1241,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1241,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1241,6,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1241,7,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1242,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1242,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1242,3,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
1242,4,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1242,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1242,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
1242,7,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1242,8,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1242,9,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1242,10,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1242,11,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1242,12,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1242,13,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1242,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1242,15,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1242,16,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1242,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1242,18,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1242,19,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1242,20,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1243,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1243,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1243,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1244,1,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1244,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1245,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1246,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
1246,2,Micrognathia,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
1247,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1247,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1247,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1247,4,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1247,5,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1247,6,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1247,7,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1247,8,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1247,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1247,10,Parathyroid disorder,Parathyroid disorders NEC,Parathyroid gland disorders,Endo,N
1247,11,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1247,12,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1247,13,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1247,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1247,15,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1248,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1248,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1248,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1248,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1248,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1249,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1249,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1249,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1249,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1249,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1249,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1250,1,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1250,2,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1250,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1250,4,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1250,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1250,6,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1250,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1250,8,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1250,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1250,10,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1250,11,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1250,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1251,1,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1251,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1251,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1252,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1252,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1252,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1252,4,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1252,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1253,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1254,1,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1255,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1255,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1256,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1257,1,Antidepressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1257,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1257,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1257,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1257,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1258,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1259,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1259,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1259,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1259,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1259,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1259,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1259,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1260,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1260,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1260,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1260,4,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1260,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1260,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1261,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1261,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1261,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1261,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1261,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1261,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1261,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1261,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1262,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1263,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1264,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1264,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1264,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1264,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
1264,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1264,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1264,7,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1264,8,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1264,9,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1264,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1264,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1264,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1264,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1265,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1265,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1265,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1265,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1266,1,Cogwheel rigidity,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1266,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1266,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1266,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1267,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1267,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1267,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1267,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1267,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1268,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1268,2,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1268,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1268,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1268,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1269,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1270,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1270,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1271,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1271,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1271,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1271,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1272,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1272,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1272,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1272,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1272,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1272,6,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1273,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1273,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1274,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1275,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1276,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1277,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1277,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1278,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1278,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1278,3,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1278,4,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1278,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1278,6,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1278,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1278,8,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1278,9,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1278,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1278,11,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1278,12,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1278,13,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1278,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1278,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1278,16,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1279,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1280,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1281,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1282,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1282,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1282,3,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
1282,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1282,5,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1282,6,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1282,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1282,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1283,1,Hypertrophic cardiomyopathy,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
1284,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1284,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1285,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1285,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1285,3,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1285,4,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1285,5,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1285,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1285,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1285,8,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1285,9,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1285,10,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1285,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1286,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1286,2,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1286,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1286,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1286,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1286,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1286,7,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1286,8,Psychomotor skills impaired,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1287,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1287,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1287,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1287,4,Headache,Headaches NEC,Headaches,Nerv,N
1287,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1287,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1287,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1287,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1287,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1288,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1289,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1290,1,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1290,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1290,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1290,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1290,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1290,6,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1290,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1291,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1291,2,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1291,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1291,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1292,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1292,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1293,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1293,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1294,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1294,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1294,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1295,1,Cholangitis acute,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1295,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1295,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1295,4,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1295,5,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1296,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1296,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1296,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1296,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1297,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1298,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1298,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1299,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1300,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1300,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1300,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1300,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1300,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1300,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1301,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1301,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1302,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1302,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1303,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1303,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1304,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1304,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1304,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1304,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1305,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1306,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1306,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1306,3,Kidney small,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
1306,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1306,5,Micturition frequency decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1306,6,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1306,7,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1306,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1306,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1307,1,Headache,Headaches NEC,Headaches,Nerv,N
1307,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1308,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1308,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1308,3,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1309,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1309,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1309,3,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1309,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1309,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1309,6,Histrionic personality disorder,Personality disorders with dramatic behaviour (Cluster B),Personality disorders and disturbances in behaviour,Psych,N
1309,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1310,1,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1310,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1310,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
1310,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1310,5,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1310,6,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1310,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1311,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1311,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1311,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1311,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1312,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1312,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1312,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1312,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1312,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1313,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1313,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1313,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1314,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1314,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1314,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1315,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1315,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1315,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1315,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1315,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1315,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1316,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1316,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1317,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1317,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1317,3,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1317,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1317,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1317,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1317,7,Pernicious anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
1317,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1317,9,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1318,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1318,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1319,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1319,2,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1319,3,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
1320,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1320,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1321,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1321,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1321,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1321,4,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1322,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1323,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1324,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1325,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1326,1,Acne,Acnes,Skin appendage conditions,Skin,N
1327,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1328,1,Headache,Headaches NEC,Headaches,Nerv,N
1329,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1330,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1330,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1331,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1331,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1331,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1331,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1331,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1331,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1331,7,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1331,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1331,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1331,10,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1331,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1331,12,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1331,13,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1331,14,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1332,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1333,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1333,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1333,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1333,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1334,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1335,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1335,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1336,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1336,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1337,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1337,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1337,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1338,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1338,2,Blood osmolarity increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
1338,3,Computerised tomogram abdomen abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
1338,4,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
1338,5,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1338,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1338,7,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1338,8,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1338,9,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1338,10,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1338,11,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1338,12,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1338,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1338,14,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1338,15,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1338,16,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1338,17,Tri-iodothyronine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1338,18,Urine calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1338,19,Urine osmolarity decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
1338,20,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1338,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1339,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1339,2,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1340,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1340,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1340,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1340,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1341,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1342,1,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1342,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1343,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1343,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1343,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1343,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1344,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1345,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1345,2,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1345,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1345,4,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1345,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1345,6,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1345,7,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1345,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1345,9,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1345,10,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1345,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1345,12,Urine osmolarity increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
1345,13,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1346,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1346,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1346,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1346,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1347,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1347,2,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1347,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1348,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1349,1,Seizure like phenomena,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1349,2,Trance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1349,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1350,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1350,2,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1351,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1351,2,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1352,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1353,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1354,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1355,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1356,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1356,2,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1357,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1358,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1359,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1360,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1361,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1362,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1363,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1364,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1364,2,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1365,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1366,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1366,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1367,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1367,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1367,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1368,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1368,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1368,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1368,4,Bipolar disorder relapse prophylaxis,Psychiatric therapies,Psychiatric therapeutic procedures,Surg,N
1368,5,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1368,6,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1368,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1368,8,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1368,9,Flight of ideas,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1368,10,Glomerular filtration rate abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1368,11,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
1368,12,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1368,13,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1368,14,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1369,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1369,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1369,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1369,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1369,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1370,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1370,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1370,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1371,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1372,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1372,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1372,3,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1372,4,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1372,5,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1372,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1372,7,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1372,8,Flight of ideas,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1372,9,Glomerular filtration rate abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1372,10,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
1372,11,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1372,12,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1373,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1373,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1373,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1374,1,Alcoholism,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1374,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1374,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1374,4,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1374,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1374,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1374,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1375,1,Dermal cyst,Skin cysts and polyps,Cutaneous neoplasms benign,Skin,N
1376,1,Headache,Headaches NEC,Headaches,Nerv,N
1376,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1376,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1376,4,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1377,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1377,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1377,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1377,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1378,1,Corneal reflex decreased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1378,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1379,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1379,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1379,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1379,4,Migraine,Migraine headaches,Headaches,Nerv,N
1380,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1381,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1381,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1381,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1381,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1381,5,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1381,6,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1381,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1381,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1381,9,Urethral stenosis,Structural and obstructive urethral disorders (excl congenital),Urethral disorders (excl calculi),Renal,N
1381,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1381,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1382,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1382,2,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1382,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1383,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1384,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1384,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1384,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1384,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1384,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1384,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1385,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1386,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1387,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1387,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1387,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1387,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1387,5,Dyspraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1387,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1387,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1388,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1388,2,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1388,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1388,4,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1388,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1388,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1389,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1389,2,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
1390,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1391,1,Ventricular tachyarrhythmia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1392,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1392,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1393,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1393,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1393,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1393,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1393,5,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1393,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1393,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1393,8,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1393,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1393,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1394,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1394,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1394,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1394,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1395,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1396,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1396,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1396,3,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1396,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1396,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1396,6,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1396,7,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1396,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1396,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1396,10,Mycoplasma infection,Mycoplasma infections,Mycoplasmal infectious disorders,Infec,N
1396,11,Mycoplasma test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1396,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1396,13,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1396,14,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1396,15,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1396,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1396,17,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1396,18,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1396,19,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1396,20,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1397,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1397,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
1398,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1398,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1398,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1398,4,Radial nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1398,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1398,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1398,7,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1398,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1399,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1399,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1399,3,Dyspraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1399,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1399,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1400,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1400,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1400,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1401,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1401,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1401,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1401,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1402,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1402,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1403,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1403,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1403,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1403,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1403,5,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1403,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1403,7,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1403,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1403,9,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1403,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1403,11,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1403,12,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1403,13,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1403,14,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1403,15,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1403,16,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1403,17,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1404,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1404,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1404,3,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1404,4,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1404,5,Fluid imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1404,6,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1404,7,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1404,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1404,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1404,10,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1405,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1405,2,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1405,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1405,4,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1405,5,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1405,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1406,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1406,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1406,3,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1406,4,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
1406,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1406,6,Pathological fracture,Fractures NEC,Fractures,Musc,N
1406,7,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1407,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1407,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1408,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1409,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1409,2,C-reactive protein,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1409,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1409,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1409,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1409,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
1409,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1409,8,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1409,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1409,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1409,11,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1409,12,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1409,13,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1409,14,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1410,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1410,2,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1411,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1411,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1411,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1412,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1412,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1413,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1413,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1413,3,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1413,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1413,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1414,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1414,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1415,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1415,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1415,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1416,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1416,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1416,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1416,4,Small size placenta,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1416,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1417,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1417,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1418,1,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
1419,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1419,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1419,3,Diet refusal,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1419,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1419,5,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1419,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1419,7,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1419,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1419,9,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1419,10,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1419,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1419,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1419,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1420,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1421,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1421,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1421,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1421,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1421,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1422,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1422,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1422,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1422,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1422,5,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1422,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1422,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1422,8,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1422,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1422,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1423,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1424,1,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
1425,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1425,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1425,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1425,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1425,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1426,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1426,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1426,3,Headache,Headaches NEC,Headaches,Nerv,N
1427,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1427,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1427,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1427,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1427,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1427,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1427,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1427,8,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1427,9,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1427,10,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1427,11,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1427,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1427,13,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1427,14,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1428,1,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
1428,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1428,3,Hyperparathyroidism primary,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1428,4,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1428,5,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1429,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1429,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1429,3,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1429,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1429,5,Oromandibular dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1429,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1429,7,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1429,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1429,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1430,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1431,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1431,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1431,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1432,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1433,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1433,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1433,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1433,4,Blunted affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1433,5,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1433,6,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1433,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1433,8,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1433,9,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1433,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1433,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1433,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
1433,13,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1433,14,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1433,15,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1434,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1434,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1434,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1435,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1436,1,Acne,Acnes,Skin appendage conditions,Skin,N
1436,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1437,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1437,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1438,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1438,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1438,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1438,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1438,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1438,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1438,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1438,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1438,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1438,10,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1438,11,Resting tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1438,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1438,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1439,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1439,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1439,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1440,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1440,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1440,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1440,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1440,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1440,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1440,7,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1440,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1441,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1441,2,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1442,1,"Follicle centre lymphoma, follicular grade I, II, III stage II",Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1442,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1442,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1442,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1442,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1442,6,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1442,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1443,1,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1443,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1443,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1444,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1444,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1444,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1444,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1445,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1445,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1446,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1446,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1447,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1448,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1448,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1449,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1450,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1451,1,Coma,Coma states,Neurological disorders NEC,Nerv,Y
1451,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
1451,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
1452,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1452,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1452,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1452,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1452,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1453,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1453,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1454,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1454,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1454,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1454,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1455,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1455,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1455,3,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1456,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1456,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1456,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1456,4,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1456,5,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1456,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1456,7,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1456,8,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1456,9,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1456,10,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1456,11,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1456,12,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1456,13,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1456,14,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1456,15,Hyperosmolar state,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1456,16,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1456,17,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1456,18,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1456,19,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1456,20,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1456,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1456,22,Urinary casts,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1456,23,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1456,24,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1457,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1457,2,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1457,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1457,4,Blood urea abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1457,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1457,6,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1457,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1457,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1457,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1457,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1458,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1458,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1458,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1458,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1459,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1459,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1459,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1459,4,Language disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1459,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1459,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1459,7,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1459,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1460,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1460,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1460,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1460,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1460,5,Headache,Headaches NEC,Headaches,Nerv,N
1460,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1461,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1462,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1463,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1464,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1465,1,Cerebellar atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1466,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1467,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1467,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1467,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1467,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1468,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1469,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1469,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1469,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1469,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1469,5,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1469,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1469,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1469,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1469,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1469,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1469,11,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1470,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1471,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1471,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1471,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1471,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1472,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
1472,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1472,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1473,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1474,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1474,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
1474,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1474,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1474,5,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1474,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1474,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1475,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1476,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1476,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1476,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1476,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1476,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1477,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1477,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1477,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1477,4,Parathyroid disorder,Parathyroid disorders NEC,Parathyroid gland disorders,Endo,N
1477,5,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1478,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1478,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1478,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1478,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1478,5,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1478,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1478,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1478,8,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1478,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1478,10,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1479,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1479,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1479,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1479,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1479,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1479,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1479,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1480,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1481,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1481,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1481,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1481,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1482,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1482,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1482,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1482,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1482,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1482,6,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1483,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1483,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1483,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1483,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1483,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1483,6,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1483,7,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1483,8,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1483,9,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1484,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1485,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1485,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1486,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1486,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1487,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1488,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1488,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1488,3,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1488,4,Sight disability,Disability issues,Lifestyle issues,SocCi,N
1488,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1489,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1489,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1489,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1490,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1491,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1492,1,Toxic nodular goitre,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1493,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1494,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1495,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1495,2,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1495,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1495,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1495,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1495,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1495,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1496,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1496,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1497,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1498,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1498,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1498,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1499,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1500,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1501,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1502,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1502,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1502,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1503,1,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1503,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1503,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1503,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1504,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1504,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1505,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1506,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1506,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1506,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1506,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1506,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1506,6,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1506,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1506,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1506,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1506,10,Product counterfeit,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1506,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1507,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1508,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1508,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1509,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1509,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1509,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1509,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1510,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1510,2,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1510,3,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1510,4,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1510,5,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1510,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1510,7,Renal hypertrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
1510,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1511,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1511,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1511,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1511,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1512,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1512,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1512,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1512,4,Nodal arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1512,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1513,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1513,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1513,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1513,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1513,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1513,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1513,7,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1513,8,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1513,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1513,10,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1513,11,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1513,12,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1513,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1513,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1513,15,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1514,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1514,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1515,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1515,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1515,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1516,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1517,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1517,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1517,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1518,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1518,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1519,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1519,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1520,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1520,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1520,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1521,1,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1521,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1521,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1522,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1522,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1523,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1523,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1523,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1523,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1523,5,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1523,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1524,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1525,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1525,2,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1525,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1525,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1525,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1525,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1526,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1526,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1527,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1527,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1527,3,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1527,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1527,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1527,6,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1527,7,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1528,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1528,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1528,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1529,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1530,1,Bipolar I disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1530,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1530,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1531,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1532,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1532,2,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
1532,3,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1532,4,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1533,1,Headache,Headaches NEC,Headaches,Nerv,N
1533,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1533,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1534,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1535,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1535,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1536,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1536,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1536,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1536,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1537,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1537,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1537,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1537,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1537,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1537,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1537,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1537,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1538,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1538,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1538,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1538,4,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1539,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1539,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1540,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1540,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
1541,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1542,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1542,2,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1542,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1543,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1544,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1544,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1544,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1544,4,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1544,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1544,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1545,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1546,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1546,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1547,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1548,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1548,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1549,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1549,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1549,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1549,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1549,5,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1549,6,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1549,7,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1549,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1549,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1549,10,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1549,11,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
1549,12,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1549,13,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1549,14,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1549,15,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1550,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1551,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1552,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1552,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1552,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1553,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1553,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1553,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1554,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1555,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1555,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1555,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1555,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1556,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1556,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1557,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1557,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
1558,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1558,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1558,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1558,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1558,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,Y
1558,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1559,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1560,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1560,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1560,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1560,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1560,5,Physical disability,Disability issues,Lifestyle issues,SocCi,N
1560,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1560,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1561,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1562,1,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1562,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1562,3,Electrocardiogram T wave abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1562,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1562,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1563,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1564,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1564,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1564,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1564,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1565,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
1565,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1565,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1566,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1567,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1567,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1567,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1567,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1567,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1567,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1567,7,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1567,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1567,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1568,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1568,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1568,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1568,4,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1569,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1569,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1570,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1570,2,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1570,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1571,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1571,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1571,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1571,4,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1571,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1571,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1571,7,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1572,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1572,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1572,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1572,4,Poor sucking reflex,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1572,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1573,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1573,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1574,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1574,2,Migraine,Migraine headaches,Headaches,Nerv,N
1575,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1575,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1575,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1575,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1576,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1577,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1577,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1577,3,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1578,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1578,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1578,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1579,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1580,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1580,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1580,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1580,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1580,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1580,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1580,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1580,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1581,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1582,1,Microphthalmos,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
1583,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1583,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1583,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1583,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1583,5,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1583,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1583,7,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1583,8,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1583,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1584,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1584,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1584,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1585,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1585,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1585,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1586,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1586,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1587,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1587,2,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1588,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1588,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1588,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1588,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1588,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1588,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1588,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1588,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1588,9,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1588,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1588,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1588,12,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1589,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1590,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1590,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1590,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1590,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1590,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1590,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1590,7,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1590,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1591,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1591,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1591,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1591,4,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1591,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1591,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1591,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1591,8,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1591,9,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1591,10,Parkinsonian rest tremor,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1591,11,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1591,12,Resting tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1591,13,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1591,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1591,15,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1592,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1592,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1592,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1592,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1593,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1593,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1593,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1594,1,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1594,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1594,3,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
1595,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1595,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1595,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1595,4,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1596,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1597,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1597,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1598,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1598,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1598,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1598,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1599,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1600,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1600,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1601,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1601,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1601,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1601,4,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1601,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1601,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1601,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1601,8,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1601,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1601,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1601,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1601,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1602,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,Y
1602,2,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1602,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1603,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1603,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1603,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1604,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1605,1,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1606,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1607,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1608,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1609,1,Parkinsonian gait,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1610,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1610,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1610,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1610,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1610,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1610,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1610,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1610,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1610,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1610,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1610,11,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1610,12,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1610,13,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1610,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1610,15,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1610,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1610,17,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1610,18,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
1610,19,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1610,20,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1610,21,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1611,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1611,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1611,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1611,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1611,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1612,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1612,2,Coating in mouth,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1612,3,Migraine,Migraine headaches,Headaches,Nerv,N
1612,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1612,5,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1613,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1613,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1613,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1614,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1614,2,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1615,1,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1615,2,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
1615,3,Congenital pulmonary artery anomaly,Arterial disorders congenital,Cardiac and vascular disorders congenital,Cong,N
1615,4,Congenital pulmonary valve atresia,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
1615,5,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1615,6,Ebstein's anomaly,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
1615,7,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1615,8,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
1615,9,Patent ductus arteriosus,Persistent foetal circulation disorders,Cardiac and vascular disorders congenital,Cong,N
1616,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1616,2,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1616,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1616,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1616,5,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1616,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1616,7,Reflexes abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1616,8,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1617,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1617,2,Atrial tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1617,3,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1617,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1617,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1618,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1618,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1619,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1619,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1619,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1620,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1620,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1620,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1620,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1621,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1621,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1622,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1622,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1623,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1623,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
1623,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1623,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1623,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1623,6,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1623,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1624,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1624,2,Hyperparathyroidism primary,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1625,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1625,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1625,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1625,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1625,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1625,6,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1625,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1625,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1626,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1626,2,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1626,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1626,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1626,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1627,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1627,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
1627,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1627,4,Long QT syndrome,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1628,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1628,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1628,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1628,4,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1628,5,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1628,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1628,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1628,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1629,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1629,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1629,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1629,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1629,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1629,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1630,1,Headache,Headaches NEC,Headaches,Nerv,N
1631,1,Microphthalmos,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
1632,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1632,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1632,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1632,4,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1632,5,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1632,6,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1632,7,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1632,8,Hyperthermia,Body temperature altered,Body temperature conditions,Genrl,N
1632,9,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1632,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1632,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1632,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1633,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1633,2,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1633,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1633,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1633,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1633,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1633,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1633,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1634,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1634,2,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1634,3,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1634,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1635,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1635,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1635,3,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1635,4,Toxic nodular goitre,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1636,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1637,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1638,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1638,2,Foreign body in respiratory tract,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
1639,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1639,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
1639,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1639,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1639,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1640,1,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
1641,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1641,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1641,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1641,4,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1641,5,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1641,6,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1641,7,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1641,8,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1641,9,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1641,10,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1641,11,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1641,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1641,13,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1641,14,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1641,15,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1641,16,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1641,17,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1641,18,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1641,19,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1641,20,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
1641,21,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1641,22,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1641,23,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1641,24,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1641,25,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1641,26,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1642,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1642,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1643,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1643,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1643,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1644,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,Y
1645,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1645,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1645,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1645,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1645,5,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1646,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1647,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1647,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1647,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1647,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1647,5,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1647,6,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1647,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1647,8,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1647,9,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1647,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1647,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1648,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1648,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1648,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1648,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1648,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1648,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1649,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1650,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1651,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1651,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1651,3,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1651,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1651,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1651,6,Myopathy,Myopathies,Muscle disorders,Musc,N
1651,7,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1651,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1651,9,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1651,10,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1652,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1652,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1653,1,Acne,Acnes,Skin appendage conditions,Skin,N
1653,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1654,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1654,2,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
1654,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1654,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1654,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1654,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1654,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1654,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1654,9,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1654,10,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1654,11,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1654,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1654,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1655,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1655,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1655,3,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1655,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1655,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1655,6,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1655,7,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1655,8,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
1655,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1655,10,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1656,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1657,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1657,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1657,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1657,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1657,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1657,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1657,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1657,8,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1657,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1657,10,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1657,11,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1657,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1657,13,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1657,14,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1657,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1657,16,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1657,17,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1657,18,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1657,19,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1657,20,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1657,21,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1657,22,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1657,23,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1657,24,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1658,1,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
1658,2,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
1659,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1660,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1661,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1662,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1662,2,Borderline personality disorder,Personality disorders with dramatic behaviour (Cluster B),Personality disorders and disturbances in behaviour,Psych,N
1662,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1662,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1662,5,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1662,6,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1662,7,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1662,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1662,9,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1662,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1662,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1662,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1662,13,Schizoaffective disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
1662,14,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1663,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1663,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1663,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1663,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1663,5,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1663,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1664,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1664,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1664,3,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1664,4,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1665,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1665,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1666,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1666,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1667,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1668,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1668,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1669,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1669,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1669,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1669,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1669,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1669,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1670,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1670,2,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1670,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1671,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1672,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1672,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1672,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1673,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1673,2,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
1673,3,Inadequate diet,Dietary and nutritional issues,Lifestyle issues,SocCi,N
1673,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1673,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1673,6,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1673,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1673,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1673,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1674,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1675,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1675,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1676,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1676,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1677,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1677,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1677,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1678,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1678,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1678,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1678,4,Language disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1678,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1678,6,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1678,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1678,8,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1679,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1679,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1680,1,Disability,Disability issues,Lifestyle issues,SocCi,N
1680,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1681,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1682,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1682,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1682,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1682,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1682,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1682,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1682,7,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1683,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1683,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1683,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1683,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1683,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1684,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1684,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1684,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1684,4,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1684,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1684,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1684,7,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1684,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1685,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1685,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1685,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1685,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1685,5,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1685,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1685,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1686,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1686,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1686,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1687,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1687,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1688,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1689,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,Y
1690,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1690,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1690,3,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1690,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1690,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1690,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1690,7,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1690,8,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1690,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1691,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1691,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1691,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,Y
1692,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1692,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1693,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1693,2,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1694,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1694,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1694,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1694,4,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1694,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1695,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1696,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1696,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1696,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1696,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1696,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1697,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1698,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1698,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1698,3,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1698,4,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1698,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1699,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1699,2,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1699,3,Blunted affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1699,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1699,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1699,6,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1699,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1699,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1699,9,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1699,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1700,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1700,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1700,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1700,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1700,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1700,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1701,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1701,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1701,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1701,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1701,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1702,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1702,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1702,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1703,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1704,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1704,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1704,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1705,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1707,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1707,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1707,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1708,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1708,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1709,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1709,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1710,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1710,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1710,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1710,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1710,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1710,6,Therapeutic drug monitoring analysis incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1710,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1710,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1711,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1712,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1713,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1713,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1714,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1714,2,Myopericarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1715,1,Essential tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1716,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1716,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1716,3,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,Y
1716,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1716,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1717,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1717,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1717,3,Tic,Tic disorders,Changes in physical activity,Psych,N
1717,4,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1718,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1718,2,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1718,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1718,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1718,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1719,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1719,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1720,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1720,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1720,3,Wrong dosage formulation,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1721,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1721,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1721,3,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1722,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1722,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1722,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1722,4,Cogwheel rigidity,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1722,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1722,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1722,7,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1722,8,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1722,9,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1722,10,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1722,11,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1722,12,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1722,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1722,14,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1722,15,Merycism,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1722,16,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1722,17,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1722,18,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1722,19,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1722,20,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1722,21,Resting tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1722,22,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1722,23,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1722,24,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1722,25,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1722,26,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1723,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1723,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1723,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1723,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1723,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1723,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1723,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1723,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1723,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1723,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1724,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1724,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1724,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1724,4,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1725,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1725,2,Altered visual depth perception,Refractive and accommodative disorders,Vision disorders,Eye,N
1725,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1725,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1725,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1725,6,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1725,7,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1725,8,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1725,9,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1725,10,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1725,11,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1725,12,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1725,13,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1725,14,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1725,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1725,16,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1725,17,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1725,18,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1725,19,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1725,20,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1725,21,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1725,22,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1725,23,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1725,24,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1726,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1726,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1726,3,Hyperparathyroidism primary,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1726,4,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1727,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1728,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1729,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1729,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1730,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1730,2,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1730,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1730,4,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1730,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1730,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
1730,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1730,8,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1730,9,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1731,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1731,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1731,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1731,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1732,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1732,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1733,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1733,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1733,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1733,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1733,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1734,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1734,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1734,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1734,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1734,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1734,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1734,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1734,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1734,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1735,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1736,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1736,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1736,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1736,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1736,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1737,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1738,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1738,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1739,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1739,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1739,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1739,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1739,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1739,6,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1739,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1739,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1739,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1740,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1740,2,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1740,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1740,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1740,5,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1740,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1741,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1741,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1742,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1742,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1743,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1744,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1744,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1745,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1745,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1746,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1746,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1746,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1746,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1747,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1747,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1748,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1749,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1750,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1751,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1752,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1752,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1752,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1752,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1752,5,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1752,6,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1753,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1753,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1753,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1753,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1754,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1754,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1754,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1754,4,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1754,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1754,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1754,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1755,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1755,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1756,1,Renal oncocytoma,Renal neoplasms benign,Renal and urinary tract neoplasms benign,Neopl,N
1757,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1757,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1757,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1758,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1758,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1758,3,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1758,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1758,5,Urine osmolarity decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
1759,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1759,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1760,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1761,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1761,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1762,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1762,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1762,3,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1763,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1763,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1763,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1763,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1763,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1764,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1764,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1764,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1764,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1764,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1764,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1765,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1766,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1766,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1767,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1768,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1768,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1768,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1768,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1769,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1769,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1769,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1770,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1770,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1770,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1771,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1771,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1771,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1771,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1772,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1772,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1772,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1772,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1772,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1772,6,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1772,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1772,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1772,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1773,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1774,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1774,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1774,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1775,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1775,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1775,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1775,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1776,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1776,2,Convulsive threshold lowered,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1776,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1776,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1777,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1777,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1777,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1777,4,Schizoaffective disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
1777,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1778,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1778,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1778,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1779,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1779,2,Altered visual depth perception,Refractive and accommodative disorders,Vision disorders,Eye,N
1779,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1779,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1779,5,Cogwheel rigidity,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1779,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1779,7,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1779,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1779,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1779,10,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1779,11,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1779,12,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1779,13,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1779,14,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1779,15,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1779,16,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1779,17,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1779,18,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1779,19,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1779,20,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1779,21,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1779,22,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1779,23,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1779,24,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1779,25,Resting tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1779,26,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1779,27,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1779,28,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1779,29,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1780,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1781,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1781,2,Thirst decreased,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1781,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1782,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1783,1,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1783,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1783,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1783,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1784,1,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1784,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1784,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1785,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1786,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1786,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1787,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1787,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1787,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1788,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1788,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1788,3,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
1788,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1788,5,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1788,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1788,7,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1788,8,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1788,9,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1788,10,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1788,11,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
1788,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1788,13,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1788,14,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1788,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
1788,16,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1788,17,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
1788,18,Patient isolation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1788,19,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1788,20,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1788,21,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1789,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1790,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1790,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1790,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1790,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1791,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1791,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1791,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1791,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1792,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1792,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1792,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1792,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1792,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1793,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1794,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1794,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1794,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1794,4,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1794,5,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1794,6,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1794,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1794,8,Disorganised speech,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
1794,9,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1794,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1794,11,Flight of ideas,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1794,12,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1794,13,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1794,14,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1794,15,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1794,16,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1794,17,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1794,18,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
1794,19,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1794,20,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1794,21,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1794,22,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1795,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1795,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1795,3,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1795,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1796,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1796,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1796,3,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1796,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1797,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1797,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1797,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1797,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1798,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1798,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1798,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1798,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
1798,5,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1798,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1798,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1798,8,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1798,9,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1799,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1800,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1800,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1801,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1801,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1801,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1801,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1802,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1802,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1802,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1802,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1802,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1803,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1803,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1804,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1804,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1805,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1805,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1806,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
1806,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1806,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1806,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1806,5,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1807,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1807,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1808,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1808,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1808,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1808,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1809,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1809,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1810,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1810,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1810,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1810,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1810,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1810,6,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1810,7,Electrocardiogram T wave abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1810,8,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1810,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1810,10,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1810,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1810,12,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1810,13,Rectal prolapse,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
1810,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1811,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1811,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1811,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1811,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1811,5,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1812,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1812,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1812,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1812,4,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1812,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1812,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1813,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1813,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1813,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1813,4,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1814,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1815,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1815,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1816,1,Cross sensitivity reaction,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1817,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1818,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1818,2,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1818,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1818,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1819,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1819,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1819,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1819,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1819,5,Hypermagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1819,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1819,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1819,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1819,9,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1820,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1820,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
1820,3,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1820,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1820,5,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1820,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1820,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1820,8,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1820,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1820,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1821,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1821,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1821,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1821,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1821,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1821,6,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1821,7,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1821,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1821,9,Throat clearing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1822,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1822,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1823,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1824,1,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
1824,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1824,3,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1825,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1825,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1825,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1825,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1825,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1825,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1826,1,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1827,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1827,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1828,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1828,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1828,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1829,1,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1830,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1830,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1830,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1830,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1830,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1831,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1832,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1833,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1833,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1834,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1834,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1835,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1836,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1837,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1837,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
1837,3,Essential tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1837,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1837,5,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1837,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1837,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1838,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1839,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1839,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
1839,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1839,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1839,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1840,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1841,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1842,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1842,2,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1842,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1843,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1843,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1844,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1844,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1845,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1845,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1845,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1845,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1845,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1845,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1846,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1846,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1846,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1846,4,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1847,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1848,1,Headache,Headaches NEC,Headaches,Nerv,N
1849,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1849,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1849,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1849,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1849,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1849,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
1849,7,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1849,8,Disease complication,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1849,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1849,10,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1849,11,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1849,12,Hyperparathyroidism secondary,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1849,13,Physical deconditioning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1849,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1850,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1850,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1851,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1851,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1851,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1851,4,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1852,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1852,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1852,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1852,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1852,5,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1852,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1853,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1853,2,Anosognosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1853,3,Blunted affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1853,4,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
1853,5,Delirium,Deliria,Deliria (incl confusion),Psych,N
1853,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1853,7,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1853,8,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1853,9,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1853,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1853,11,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1853,12,Mutism,Communications disorders,Communication disorders and disturbances,Psych,N
1853,13,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1853,14,Persecutory delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1853,15,Poverty of speech,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
1853,16,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1853,17,Psychomotor retardation,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1853,18,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1853,19,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1853,20,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1853,21,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1854,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1854,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1854,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1854,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1854,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1854,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1855,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1855,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1856,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1857,1,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1858,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1858,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1859,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1859,2,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1860,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1861,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1862,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1862,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1862,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1862,4,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1862,5,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1862,6,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1862,7,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1862,8,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1862,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1862,10,Renal tubular atrophy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1863,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1863,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
1864,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1865,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1865,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1865,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1865,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1865,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1865,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1865,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1866,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1866,2,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1866,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1867,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1868,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1868,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1869,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1869,2,Headache,Headaches NEC,Headaches,Nerv,N
1870,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1870,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1870,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1871,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1872,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1873,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1874,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1874,2,Glomerular filtration rate increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1875,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1875,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1876,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1877,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1877,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1878,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1879,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1879,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1880,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1880,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1880,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1881,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1881,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1881,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1881,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1881,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1881,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1882,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1882,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1883,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1883,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1884,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1884,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1884,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1884,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1884,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1885,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1885,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1885,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1886,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1886,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1887,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1887,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1887,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1887,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1887,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1888,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1889,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1889,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1889,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1889,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1889,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1889,6,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1889,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1889,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1889,9,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1889,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1890,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1890,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1891,1,Autoimmune thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1892,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1892,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1892,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1893,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1894,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1894,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1895,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1896,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1896,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1896,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1896,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1896,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1896,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1897,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1897,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1897,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1897,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1898,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1898,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1899,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1899,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1899,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1900,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1901,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1902,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
1902,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1902,3,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1902,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1903,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1903,2,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1903,3,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1903,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1904,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1904,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1904,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1904,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1904,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1904,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1905,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1906,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1907,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1907,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1907,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1908,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1908,2,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1908,3,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1909,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1910,1,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1911,1,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1912,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1913,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1913,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1913,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1913,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1913,5,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1913,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1913,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1913,8,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1913,9,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1913,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1913,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1913,12,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1913,13,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1913,14,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1913,15,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1913,16,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1913,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1913,18,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1913,19,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1913,20,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1913,21,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1913,22,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1913,23,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1913,24,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1913,25,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1913,26,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1913,27,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1914,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1914,2,Blood chloride increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1914,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1914,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1914,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1915,1,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1915,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1916,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1916,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1916,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1917,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1918,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1918,2,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1919,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1919,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1920,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1920,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1921,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1921,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1922,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1923,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1923,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1923,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1923,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1924,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1924,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
1924,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1924,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1925,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1925,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1925,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1925,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1926,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1927,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1927,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1927,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1927,4,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1927,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1927,6,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1927,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1928,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1928,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1929,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1930,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1931,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1931,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1931,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1931,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1931,5,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1931,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1931,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1931,8,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1931,9,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1931,10,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1931,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1931,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1931,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1931,14,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1931,15,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1931,16,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1931,17,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1931,18,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1931,19,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1931,20,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1931,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1931,22,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1931,23,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1931,24,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1931,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1931,26,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1931,27,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1931,28,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1931,29,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1931,30,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1931,31,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1931,32,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1931,33,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1932,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1933,1,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1933,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1934,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1934,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1935,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
1935,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1935,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1935,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1936,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1936,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1937,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
1937,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1937,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1937,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1937,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1939,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1940,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1941,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1941,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1941,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1941,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1941,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1942,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1943,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1943,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1943,3,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
1943,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1943,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1943,6,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1943,7,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1943,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1943,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1943,10,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1943,11,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1943,12,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1943,13,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1943,14,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1943,15,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1943,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1944,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1945,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1946,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1946,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1947,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1948,1,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1948,2,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1948,3,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1948,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1949,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1950,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1950,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1951,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1952,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1952,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
1953,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1953,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1954,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1954,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1954,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1954,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1954,5,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1954,6,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1954,7,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1954,8,Suspected product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1955,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1956,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1957,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1958,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1958,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1958,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1958,4,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
1958,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1958,6,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1959,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1959,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1960,1,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1960,2,Cystitis interstitial,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1961,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1961,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1962,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1962,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1963,1,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
1964,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1964,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1964,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1965,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1966,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1966,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1966,3,Kidney small,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
1966,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1967,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1968,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1968,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1968,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1969,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1969,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1969,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1970,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1970,2,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
1970,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1970,4,Coma,Coma states,Neurological disorders NEC,Nerv,N
1970,5,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1970,6,Foetal arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1970,7,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1970,8,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
1970,9,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1970,10,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1970,11,Hypotonia neonatal,Muscle tone abnormalities,Muscle disorders,Musc,N
1970,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1970,13,Muscle tone disorder,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1970,14,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1970,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1970,16,Tremor neonatal,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1971,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1972,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1973,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1973,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1973,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1973,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1974,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1975,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1976,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1977,1,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1977,2,Headache,Headaches NEC,Headaches,Nerv,N
1977,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1977,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1977,5,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1977,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1977,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1977,8,Temporomandibular pain and dysfunction syndrome,Joint related disorders NEC,Joint disorders,Musc,N
1977,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1978,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1978,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1978,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1978,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1978,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1979,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1980,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1980,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1980,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1981,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1981,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1981,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1981,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1981,5,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1981,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1981,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1981,8,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1981,9,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1981,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1981,11,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1981,12,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1981,13,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1981,14,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1981,15,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1981,16,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1981,17,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1981,18,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1981,19,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1981,20,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1981,21,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1981,22,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1981,23,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1981,24,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1981,25,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1981,26,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1981,27,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1981,28,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1981,29,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1981,30,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1981,31,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1982,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,Y
1982,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1982,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1982,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1982,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1982,6,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1983,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1983,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1983,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1983,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1983,5,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1983,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1983,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1983,8,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1983,9,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1983,10,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1984,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1984,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1984,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1984,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1984,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1984,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1984,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1984,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1984,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1984,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1984,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1984,12,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,Y
1984,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1984,14,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1985,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1985,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1985,3,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1985,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1985,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1986,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1987,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1988,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1989,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1990,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1990,2,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1990,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1990,4,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1990,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1990,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1990,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1991,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1991,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1991,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1992,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1993,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1993,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1993,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1994,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1994,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1994,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1995,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1996,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1996,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1996,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1996,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1996,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1996,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1996,7,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
1996,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1996,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1996,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1997,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1998,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1999,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1999,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1999,3,Headache,Headaches NEC,Headaches,Nerv,N
1999,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1999,5,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1999,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2000,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2000,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2000,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2000,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2000,5,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
2000,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2000,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2000,8,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2000,9,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2000,10,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2000,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2000,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2000,13,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2000,14,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2000,15,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2000,16,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2000,17,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2000,18,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2000,19,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2000,20,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2000,21,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2000,22,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2000,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2000,24,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2000,25,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2000,26,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2000,27,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2000,28,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2000,29,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2000,30,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2000,31,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2000,32,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2000,33,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2000,34,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2000,35,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2000,36,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
2000,37,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2000,38,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2001,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2002,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2003,1,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2003,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2004,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2004,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2004,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2004,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2004,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2004,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2005,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2006,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2006,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2007,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2008,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2008,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2008,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2008,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2008,5,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
2008,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2008,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2008,8,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2008,9,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2008,10,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2008,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2008,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2008,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2008,14,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2008,15,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2008,16,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2008,17,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2008,18,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2008,19,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2008,20,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2008,21,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2008,22,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2008,23,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2008,24,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2008,25,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2008,26,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2008,27,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2008,28,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2008,29,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2008,30,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2008,31,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2008,32,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2008,33,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2008,34,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2008,35,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2008,36,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
2008,37,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2008,38,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2009,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2010,1,Amblyopia,Amblyopic vision impairment,Vision disorders,Eye,N
2010,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2010,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2010,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2010,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2010,6,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2011,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
2011,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2012,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2012,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
2013,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2013,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2013,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2014,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
2015,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2016,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2016,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2017,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2017,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2017,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2017,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
2017,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2017,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2018,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2018,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
2018,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2018,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2018,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2019,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2019,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2019,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
